Press Release
The Prostate Cancer Foundation Announces 2004 Competitive Award Recipients
Using Their Venture Philanthropy Model, 25 Top Medical and Scientific Researchers From 11 States, Israel and the Netherlands Are Given $2.3 Million for Research
New York - March 23, 2005 - The Prostate Cancer Foundation today announced the recipients of the Foundation's 2004 Competitive Research Awards. This venture-style research funding mechanism provides support to high-impact research projects with the greatest likelihood of providing improved near-term treatments for men with prostate cancer.
The awards are made in a variety of research areas including genomics, molecular biology, angiogenesis, signal transduction, experimental models, apoptosis, new drug discovery, nutrition, alternative therapies and clinical medicine. Since the program was established in 1993, emphasis has shifted from basic science to specific treatment applications. The 2004 awards focus on applications of stem cell biology, the discovery of novel therapeutics and the clinical development of exciting new drugs.
Leslie D. Michelson, vice chairman and chief executive officer of the Prostate Cancer Foundation commented, “We are pleased to distribute the Competitive Awards to such deserving and dedicated recipients. The awards represent the PCF’s commitment to the search for better treatments and a cure for recurrent prostate cancer. This year, we granted Competitive Awards totaling $2.3 million to 25 scientists and physicians. As the largest non-profit supporter of breakthrough science in prostate cancer, we are proud of our role in recruiting new talent to this arena, and we believe our Awards Program continues to play an important part in sparking innovative and novel ideas in drug discovery and development.”
The Prostate Cancer Foundation's 2004 Competitive Award recipients are:
Tanja D. de Gruijl, Ph.D. - Vrije Universiteit medisch centrum, the Netherlands
Samuel R. Denmeade, M.D. – The Johns Hopkins School of Medicine
Phillip Febbo, M.D. - Duke Institute for Genome Sciences and Policy
Stephen J. Freedland, M.D. – The Johns Hopkins School of Medicine
Michael E. Jung, Ph.D. - University of California, Los Angeles
Richard P. Junghans, M.D., Ph.D. - Roger Williams Medical Center
Michael Karin, Ph.D. - University of California, San Diego
Clara L. Kielkopf, Ph.D. – The Johns Hopkins University
Dolores J. Lamb, Ph.D. - Baylor College of Medicine
Sue-Hwa Lin, Ph.D. - The University of Texas M. D. Anderson Cancer Center
Massimo Loda, M.D. - Dana Farber Cancer Institute
Valeri V. Mossine, Ph.D. - University of Missouri-Columbia
Nora M. Navone, M.D., Ph.D. - The University of Texas M. D. Anderson Cancer Center
Renata Pasqualini, Ph.D. - The University of Texas M. D. Anderson Cancer Center
Amnon Peled, Ph.D. - Hadassah University Hospital, Israel
Roberto Pili, M.D. – The Johns Hopkins University
Yun Qiu, Ph.D. - University of Maryland School of Medicine
Neal Rosen, M.D., Ph.D. - Memorial Sloan-Kettering Cancer Center
Howard I. Scher, M.D. - Memorial Sloan-Kettering Cancer Center
Meir J. Stampfer, M.D., Sc.D. - Harvard School of Public Health
Dean G. Tang, M.D., Ph.D. - The University of Texas M. D. Anderson Cancer Center
Shaomeng Wang, Ph.D. - University of Michigan Comprehensive Cancer Center
Michael J. Weber, Ph.D. - University of Virginia Health System
George Wilding, M.D. - University of Wisconsin Comprehensive Cancer Center
Owen N. Witte, M.D. - Howard Hughes Medical Institute/UCLA
More information on each award program can be found at Competitive Awards Table.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation is the world's largest philanthropic source of support for prostate cancer research. Founded in 1993, the PCF has raised more than $230 million and provided funding for prostate cancer research to more than 1,200 researchers at 100 institutions worldwide. PCF has a simple, yet urgent goal: to find better treatments and a cure for prostate cancer. For more information, please visit Prostate Cancer Foundation.
Sarah Evans
(310) 570-4705
sevans@prostatecancerfoundation.org
Katie Lambe
(310) 570-4713
klambe@prostatecancerfoundation.org
|
